Alcohol-mediated enhancement of postprandial lipemia: A contributing factor to an increase in plasma HDL and a decrease in risk of cardiovascular disease

American Journal of Clinical Nutrition

Volumn 78, Issue 3, 2003, Pages 391-399

  Chung, Byung Hong ^a   Doran, Steve ^a   Liang, Ping ^a   Osterlund, Laura ^a   Cho, B H Simon ^d   Oster, Robert A ^a,c   Darnell, Betty ^c   Franklin, Frank ^b,c  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Alcohol; Cholesteryl ester transfer proteins; High density lipoproteins; Postprandial lipemia; Reverse cholesterol transport; Triacylglycerol rich lipoproteins

Indexed keywords

ALCOHOL; CHOLESTEROL ACYLTRANSFERASE; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE; TRIACYLGLYCEROL; CARRIER PROTEIN; CETP PROTEIN, HUMAN; CHOLESTEROL; GLYCOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE;

ARTICLE; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; ERYTHROCYTE; HUMAN; HYPERLIPIDEMIA; INCUBATION TIME; LIPID BLOOD LEVEL; LIPOLYSIS; MEAL; TRIACYLGLYCEROL BLOOD LEVEL; ADULT; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRINKING BEHAVIOR; ERYTHROCYTE MEMBRANE; FEMALE; LIVER; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL; RISK; TRANSPORT AT THE CELLULAR LEVEL;

ADULT; ALCOHOL DRINKING; BIOLOGICAL TRANSPORT; CARDIOVASCULAR DISEASES; CARRIER PROTEINS; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; ERYTHROCYTE MEMBRANE; FEMALE; GLYCOPROTEINS; HUMANS; LIPOPROTEINS; LIVER; MALE; MIDDLE AGED; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; POSTPRANDIAL PERIOD; RISK; TRIGLYCERIDES;

EID: 0141608669     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/78.3.391     Document Type: Article

References (45)

1. Stampfer MJ, Colditz GA, Willett WC, Speizer, Hennekens CH. Prospective studies of moderate alcohol consumption and the risk of coronary heart disease and stroke in women. N Engl J Med 1988;319:267-73.
2. Fraser GE, Upsdell M. Alcohol and other discriminants between cases of sudden death and myocardial infraction. Am J Epidemiol 1981; 114:462-76.
3. Klasky AL. Epidemiology of coronary heart disease: influence of alcohol. Alcohol Clin Exp Res 1999;18:88-99.
4. Wannamethee SG, Shaper AG. Type of alcoholic drink and risk of major coronary heart disease events and all-cause mortality. Am J Public Health 1999;89:685-90.
5. Gaziano JM, Buring JE, Breslow JL, et al. Moderate alcohol intake increased levels of high density lipoproteins and its subfractions and decreased risk of myocardial infarction. N Engl J Med 1993;329: 1829-34.
6. Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ 1999;319: 1523-8.
7. Castelli WP, Doyle JT, Gordon T Alcohol and blood lipids: the cooperative lipoprotein phenotyping study. Lancet 1977;2:153-5.
8. Gordon T, Castelli WP, Hjortland WC, Kannel WP, Dawber TR. High density lipoproteins as a protective factor against coronary heart disease. The Framingham study. Am J Med 1977;62:707-14.
9. Wilson DE, Schreibman PH, Brewster AC, Arky AR. The enhancement of alimentary lipemia by ethanol in man. J Lab Clin Invest 1970; 75:264-74.
10. Rose HG, Juliano J. Regulation of plasma lecithin cholesterol acyltransferase in man. Activation during alimentary lipemia. J Lab Clin Med 1977;89:524-32.
11. Tall AR. Plasma cholesterylester transfer protein. J Lipid Res 1993; 34:1255-74.
12. Glomset JA, Norum KR. The metabolic role of lecithin:cholesterol acyltransferase: perspective from pathology. Adv Lipid Res 1973; 11:1-65.
13. Berard AM, Remaley AT, Vaisman BL, et al. High plasma HDL concentration associated with enhanced atherosclerosis in transgenic mice overexpressing lecithin cholesterol acyltransferase. Nat Med 1997;3:744-9.
14. Hayek TL, Masucci-Magoulas L, Jiang X, et al. Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene. J Clin Invest 1995;96: 2071-4.
15. Ebara T, Ramarkrishnan R, Steiner G, Schachter NS. Chylomicronemia due to apolipoprotein C-III overexpression in apolipoprotein E-null mice. J Clin Invest 1997;99:2672-81.
16. Forger B, Chase M, Amar MJ, et al. Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice. J Biol Chem 1999;274:36912-20.
17. Chung BH, Franklin F, Cho BHS, Segrest JP, Hart H, Darnell B. Potencies of lipoproteins in fasting and postprandial plasma to accept additional cholesterol molecules released from cell membranes. Arterioscler Thromb Vasc Biol 1998;18:1217-30.
18. Chung BH, Segrest JP, Ray ML, et al. Single vertical spin density gradient ultracentrifugation. Methods Enzymol 1986;128: 181-209.
19. 3H-cholesterylester labeling and transfer among human and nonhuman primate plasma lipoproteins. Anal Biochem 1983;130:890-4.
20. Chung BH, Segrest JP. Resistance of a very low density lipoprotein subpopulation from familial dysbetalipoproteinemia to in vitro lipolytic conversion to the low density lipoprotein density fraction. J Lipid Res 1983;24:1148-59.
21. Tall AR, Small DM. Body cholesterol removal: role of plasma high density lipoproteins. Adv Lipid Res 1980;17:1-51.
22. Simons LA, Dwyer T, Simons J, et al. Chylomicrons and chylomicron remnants in coronary artery disease: a case control study. Atherosclerosis 1987;65:181-9.
23. Myer E, Westerveld HT, Ruyter FCD, et al Abnormal postprandial apolipoprotein B-48 and triglyceride responses in normolipidemic women with greater than 70% stenotic coronary artery disease: a case control study. Atherosclerosis 1996;124: 221-35.
24. Dalloneville J, Fruchart J-C. Postprandial dyslipidemia, a risk factor for coronary heart disease. Ann Nutr Metab 1998;42:1-11.
25. Ajani UA, Gaziano JM, Lotufo PA, et al. Alcohol consumption and risk of coronary heart disease by diabetes status. Circulation 2000; 102:500-5.
26. Criqui MH. Do known cardiovascular risk factors modulate the effect of alcohol on cardiovascular disease? Novatis Found Symp 1998;83:52-7.
27. Pownall HJ. Dietary ethanol is associated with reduced lipolysis of intestinally derived lipoproteins. J Lipid Res 1994;35:2105-13.
28. Karpe F, Steiner G, Uffelman K, Olivercrona T, Hamsten A. Postprandial lipoproteins and progression of atherosclerosis. Atherosclerosis 1994;106:83-97.
29. Patsch JR, Miesnbock G, Hopferweiser T, et al. Relation of triglyceride metabolism and coronary artery disease: studies in postprandial state. Arterioscler Thromb 1992;12:1336-45.
30. Dubois C, Armand M, Azais-Braesco V, et al. Effect of moderate amount of emulsified dietary fat on postprandial lipemia and lipoproteins in normolipidemic adults Am J Clin Nutr 1994;60: 374-82.
31. Franceschini G, Moreno Y, Apebe P, et al. Alteration in high density lipoprotein subfractions during postprandial lipemia induced by fat with and without alcohol. Clin Sci 1988;75:135-42.
32. Van Tol A, Groener JEM, Scheek LM, et al. Induction of net mass transfer reactions in plasma by wine consumption with dinner. Eur J Clin Invest 1995;25:390-5.
33. Dubois C, Armand M, Ferezou J, et al. Postprandial appearance of dietary deuterated cholesterol in the chylomicron fraction and whole plasma in healthy subjects. Am J Clin Nutr 1996;64:47-52.
34. Lally JI, Barter PJ. The in vivo metabolism of esterified cholesterol in the plasma high density lipoproteins in rabbits. J Lab Clin Med 1979;93:570-82.
35. Oliviera HCF, Nilausen K, Meinertz H, Quintao ERC. Cholesterylester in lymph chylomicrons: contribution from high density lipoproteins in plasma into intestinal lymph. J Lipid Res 1993;34: 1729-36.
36. Castro GR, Fielding CJ. Effect of postprandial lipemia on plasma cholesterol metabolism. J Clin Invest 1985;75:874-82.
37. van der Gaag MS, van Tol A, Vermunt SH, Scheek LM, Schaafsma G, Hendriks HF. Alcohol consumption stimulates early steps in reverse cholesterol transport. J Lipid Res 2001;42:2077-83.
38. Cooper AD. Hepatic uptake of chylomicron remnants. J Lipid Res 1997;38:2173-92.
39. Dufour MC. What is moderate drinking? Defining "drinks" and drinking levels. Alcohol Res Health 1999;23:5-14.
40. Schneider J, Liesenfeld A, Mordasisni R, et al. Lipoprotein fractions, lipoprotein lipase and hepatic triglyceride lipase during short-term and long-term uptake of ethanol in healthy subjects. Atherosclerosis 1985;57:281-91.
41. Esko TS, Nikkila A, Taskinen MR, Valimaki M, Yikahri R. Accelerated turnover of very low density lipoprotein triglycerides in chronic alcohol user. Atherosclerosis 1984;53:185-93.
42. Malmendier CL, Delcroix C. Effect of alcohol intake on high and low density lipoprotein metabolism in healthy volunteers. Clin Chim Acta 1985;152:281-8.
43. Hojnaski JL, Cluette-Brown JE, Dawson M. Alcohol delays clearance of lipoproteins from circulation. Metabolism 1992;41: 1151-3
44. Savolainen MJ, Honnuksela M, Seppanen S, Kervinen K, Kesaniemi YA. Increased high density lipoprotein cholesterol concentration in alcoholics is related to low cholesterylester transfer protein activity. Eur J Clin Invest 1990;20:593-9.
45. Rumpler WV, Clevidence BA, Muesing RA, Rhodes DG. Change in women's plasma lipid and lipoprotein concentrations due to moderate consumption of alcohol are affected by dietary fat level. J Nutr 1999;129:1713-7.